News Corporate Actions Neogen Chemicals Grants 50,200 Stock Options in Tranche II Under ESOP Scheme 2024Neogen Chemicals Grants 50,200 Stock Options in Tranche II Under ESOP Scheme 2024
Neogen Chemicals Limited's Nomination and Remuneration Committee approved granting 50,200 stock options to 55 employees in Tranche II at Rs. 1,183.14 per option under the NCL ESOP Scheme 2024 on February 11, 2026. The committee also approved vesting of 4,650 options from Tranche I originally granted on April 1, 2025. The ESOP scheme permits maximum 2,50,000 options representing 0.95% of paid-up share capital, with structured vesting over three years and exercise period of up to two years post-vesting.
*this image is generated using AI for illustrative purposes only.
Neogen Chemicals Limited has announced significant developments in its Employee Stock Option Plan, with the Nomination and Remuneration Committee approving both new option grants and vesting of previously allocated options under the NCL ESOP Scheme 2024.
Tranche II Option Grant Details
The company's Nomination and Remuneration Committee, in its meeting held on February 11, 2026, approved the grant of 50,200 stock options in Tranche II to 55 eligible employees of the company and its subsidiaries in India. Each option is convertible into one equity share of face value Rs. 10 each.
| Parameter: | Details |
|---|---|
| Options Granted: | 50,200 |
| Eligible Employees: | 55 |
| Exercise Price: | Rs. 1,183.14 per option |
| Discount: | 10% to market price |
| Grant Date: | February 11, 2026 |
The exercise price of Rs. 1,183.14 per option represents a 10% discount to the market price, calculated based on the closing price on the National Stock Exchange on the previous trading day.
Vesting Schedule for Tranche II
The Tranche II options will vest over a three-year period following a structured timeline:
| Vesting Date: | Percentage Vested |
|---|---|
| April 1, 2027: | 25% of eligible options |
| April 1, 2028: | 25% of eligible options |
| April 1, 2029: | 50% of eligible options |
After vesting, options can be exercised within a maximum period of 2 years from the respective vesting date.
Tranche I Vesting Approval
Simultaneously, the committee approved the vesting of 4,650 employee stock options from Tranche I, which were originally granted to employees on April 1, 2025. The Tranche I grant involved 36,400 options distributed among 41 eligible employees at an exercise price of Rs. 1,389 per option.
| Tranche I Details: | Information |
|---|---|
| Original Grant: | 36,400 options |
| Options Vested: | 4,650 options |
| Original Grant Date: | April 1, 2025 |
| Exercise Price: | Rs. 1,389 per option |
ESOP Scheme Framework
The NCL ESOP Scheme 2024 allows for a maximum of 2,50,000 options, representing 0.95% of the company's total paid-up share capital. The scheme is implemented through a trust route, where the trust may acquire shares through secondary market acquisition or fresh allotment from the company.
Key features of the scheme include:
- Vesting period: Minimum 1 year to maximum 5 years from grant date
- Exercise period: Maximum 2 years from vesting date
- Exercise price linked to market price with committee-approved discounts
- Shares rank pari-passu with existing equity shares
- No lock-in period for allotted shares
The scheme is administered by the Nomination and Remuneration Committee, which delegates administrative powers to the trust for proper scheme management. All equity shares allotted pursuant to option exercise will rank equally with existing equity shares in all respects.
Historical Stock Returns for Neogen Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.47% | -2.89% | +14.54% | -8.68% | -36.62% | +73.84% |
20
